Readership
Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Cardiologists, Cardiovascular Surgeons, Cell Biologists, Clinical Engineers, Clinicians, Immunologists, Industrial Hygienists, Industrial Scientists, Molecular Biologists, Policy Makers, Pulmonologists, Scientists
Scope
Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. The journal is focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.
The journal covers all areas of clinical and translational medicine (CTM) but specializes in several Themed Topics: Education and Career Development, Clinical Studies of Drugs and Devices, Target-Based Drug Discovery and Development, Clinical Bioinformatics, Clinical Trans-omics, Single-cell Biomedicine, Stem Cell Biology and Therapy, Clinical Genomics, Vaccines and Immunotherapy, Chronic Metabolic Diseases.